2015 to 2021 Saw Decrease in Incidence of Dementia
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, May 23, 2025 -- From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study published online May 20 in The BMJ.
Beau Blass, M.P.H., from Duke University School of Medicine in Durham, North Carolina, and colleagues examined the incidence and prevalence of dementia in a nationally representative cohort of U.S. Medicare beneficiaries in a population-based study.
The researchers documented 5,025,039 incident cases of dementia from 2015 to 2021. There was a decrease in the overall age and sex standardized incidence between 2015 and 2021, from 3.5 to 2.8 percent. During the same time, prevalence increased from 10.5 to 11.8 percent. Higher age standardized incidence was seen for male versus female beneficiaries in 2015 (3.5 versus 3.4 percent); the difference increased by 2021 (2.9 versus 2.6 percent; estimated difference-in-difference, 0.94). In 2015, incidence was highest for Black beneficiaries, followed by Hispanic and White beneficiaries (4.2, 3.7, and 3.4 percent, respectively); in 2021, incidence was 3.1, 2.8, and 2.6 percent for Black, White, and Hispanic beneficiaries, respectively, with the differences between White and Black and White and Hispanic beneficiaries narrowing from 2015 to 2021 (estimated difference-in-differences, 0.92 and 0.88, respectively).
"The burden of dementia was unequally distributed, with the highest incidence and prevalence of dementia among Black beneficiaries and those living in socioeconomically deprived neighborhoods," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-24 12:00
Read more

- FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia
- President Signs Executive Order to Lower Some Drug Costs
- Medicaid 'Unwinding' Cost Kids Access To Asthma Inhalers, Other Chronic Disease Meds
- Most Americans Want Easy Early Testing For Alzheimer's
- NIH Research Cuts Leave Cancer Patient Facing Hard Choice
- Second Opinions Don't Significantly Delay Breast Cancer Treatment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions